- Companies
- Pershing Square
Pershing Square Valuation Multiples
Pershing Square is valued at $20B as of November 2026, a 69.6x revenue multiple. In the last 12 months, Pershing Square revenue was $293M and Pershing Square EBITDA was $247M.
Pershing Square Overview
About Pershing Square
Pershing Square is a United States investment-management business associated with Pershing Square Capital Management and its publicly listed parent. The manager follows a concentrated, research-intensive approach to investing in large public companies and selected private or strategic opportunities. It manages permanent capital and other investment vehicles for shareholders and institutional investors. The business earns management and performance-related fees from the capital it oversees. Pershing Square and its affiliated funds had invested in Howard Hughes Holdings for many years before a newly formed Pershing Square holding company completed a separate primary investment in 2025. That transaction gave the group a larger strategic position and an advisory role as Howard Hughes began transforming into a diversified holding company. Pershing Square therefore operates as an asset manager and investment platform rather than as an operating company in the industries represented by its portfolio holdings.
Founded
2024
HQ
Employees
44
Website
N/A
Sectors
Financials (LTM)
EV
$20B
Valuation Multiples
Start free trialPershing Square Financials
Pershing Square reported last 12-month revenue of $293M and EBITDA of $247M.
In the same LTM period, Pershing Square generated $247M in EBITDA and $187M in net income.
Revenue (LTM)
Pershing Square P&L
In the most recent fiscal year, Pershing Square reported revenue of $750M and EBITDA of ($220M).
Pershing Square is unprofitable as of last fiscal year, with gross margin of 95%, EBITDA margin of (29%), and net margin of (28%).
Financial data powered by Morningstar, Inc.
Pershing Square Stock Performance
Pershing Square has current market cap of $20B, and enterprise value of $20B.
Market Cap Evolution
Pershing Square's stock price is $50.34.
Pershing Square share price increased by 10.2% in the last 30 days.
Pershing Square has an EPS (earnings per share) of $-0.53.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $20B | $20B | -4.7% | 10.2% | 17.3% | - | $-0.53 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPershing Square Valuation Multiples
Pershing Square trades at 69.6x EV/Revenue multiple, and 82.7x EV/EBITDA.
EV / Revenue (LTM)
Pershing Square Financial Valuation Multiples
As of November 6, 2026, Pershing Square has market cap of $20B and EV of $20B.
Pershing Square has a P/E ratio of 107.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pershing Square Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Pershing Square Margins & Growth Rates
Pershing Square decreased revenue by 62% and EBITDA by 207% in the last fiscal year.
In the most recent fiscal year, Pershing Square reported gross margin of 95%, EBITDA margin of (29%), and net margin of (28%).
Pershing Square Margins
Pershing Square Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Pershing Square Operational KPIs
Pershing Square's revenue per employee in the last FY averaged $17.0M, while opex per employee averaged $24.2M for the same period.
Pershing Square's Rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pershing Square's Rule of X is (73%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Pershing Square Competitors
Pershing Square competitors include Scottish Mortgage IT, GF Securities, Partners Group, Amundi, 2PointZero, Legal & General, CVC Capital Partners, ASR Nederland, KGI Financial and HAL Trust.
Most Pershing Square public comparables operate across Asset Management.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $4.2B | - | 5.5x | - | - | - | |||
| $5.1B | $1.9B | 4.2x | 3.1x | 11.5x | 8.7x | |||
| $3B | $2B | 8.1x | 8.6x | 12.2x | 13.7x | |||
| $7.2B | $2.4B | 2.6x | 4.7x | 7.9x | 10.2x | |||
| $1.9B | $1.3B | 7.2x | - | 10.3x | - | |||
| $57B | $1.3B | 0.7x | 1.9x | 29.5x | - | |||
| $2.1B | $1.6B | 9.6x | 9.5x | 12.4x | 15.7x | |||
| $15B | $7.3B | 1.2x | 1.6x | 2.4x | 9.2x | |||
This data is available for Pro users. Sign up to see all Pershing Square competitors and their valuation data. Start Free Trial | ||||||||
Pershing Square VC Funding History
Before going public, Pershing Square raised $1.1B in total equity funding, across 1 round.
Last private valuation of Pershing Square was $11B, after raising $1.1B in June 2024 from ICONIQ Capital, Consulta, Menora Mivtachim, and 2 other investors.
Pershing Square Funding Rounds
Investments by Pershing Square
Pershing Square has invested in 2 companies to date.
Latest investment by Pershing Square was on September 24th 2026. Pershing Square invested in Precision Neuroscience in their $250M Series D round (EV/Revenue multiple available to Pro users).
Latest Investments by Pershing Square
| Description | Precision Neuroscience is a New York-headquartered developer of brain-computer interface technology. Founded in 2021, it creates minimally invasive, removable cortical implants capable of high-resolution neural recording to treat neurological disorders affecting billions globally. | Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers. |
| HQ Country | ||
| HQ City | New York City, NY | Houston, TX |
| Deal Date | 24 Sep 2026 | 5 May 2025 |
| Round | Series D | Strategic investment |
| Raised | $250M | $900M |
| Investors | Invus; Korea Investment Partners; Duquesne Family Office; Hitachi Ventures; ARK Investment Management; Pershing Square; JSL Health Capital; Mubadala Capital; B Capital; Mirae Asset Capital | Pershing Square |
| Valuation | $1B | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Pershing Square investments and their VC round multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pershing Square
| When was Pershing Square founded? | Pershing Square was founded in 2024. |
| Where is Pershing Square headquartered? | Pershing Square is headquartered in United States. |
| How many employees does Pershing Square have? | As of today, Pershing Square has over 44 employees. |
| Is Pershing Square publicly listed? | Yes, Pershing Square is a public company listed on NYSE. |
| What is the stock symbol of Pershing Square? | Pershing Square trades under PS ticker. |
| When did Pershing Square go public? | Pershing Square went public in 2026. |
| Who are competitors of Pershing Square? | Pershing Square main competitors include Scottish Mortgage IT, GF Securities, Partners Group, Amundi, 2PointZero, Legal & General, CVC Capital Partners, ASR Nederland, KGI Financial, HAL Trust. |
| What is the current market cap of Pershing Square? | Pershing Square's current market cap is $20B. |
| What is the current revenue of Pershing Square? | Pershing Square's last 12 months revenue is $293M. |
| What is the current revenue growth of Pershing Square? | Pershing Square revenue growth (NTM/LTM) is 65%. |
| What is the current EV/Revenue multiple of Pershing Square? | Current revenue multiple of Pershing Square is 69.6x. |
| What is the current EBITDA of Pershing Square? | Pershing Square's last 12 months EBITDA is $247M. |
| What is Pershing Square's EBITDA margin? | Pershing Square's last 12 months EBITDA margin is 84%. |
| What is the current EV/EBITDA multiple of Pershing Square? | Current EBITDA multiple of Pershing Square is 82.7x. |
| What is the current FCF of Pershing Square? | Pershing Square's last 12 months FCF is $209M. |
| What is Pershing Square's FCF margin? | Pershing Square's last 12 months FCF margin is 71%. |
| What is the current EV/FCF multiple of Pershing Square? | Current FCF multiple of Pershing Square is 97.8x. |
| How many companies Pershing Square has acquired to date? | Pershing Square hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Pershing Square has invested to date? | As of November 2026, Pershing Square has invested in 2 companies. |
| What was the last Pershing Square investment? | On 24th September 2026 Pershing Square invested in Precision Neuroscience, participating in a $250M Series D round at $1B valuation, alongside Invus, Korea Investment Partners, Duquesne Family Office, Hitachi Ventures, ARK Investment Management, JSL Health Capital, Mubadala Capital, B Capital, and Mirae Asset Capital. |
| In what companies Pershing Square invested in? | Pershing Square invested in Howard Hughes Holdings and Precision Neuroscience. |
See public comps similar to Pershing Square
Lists including Pershing Square
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




